| 000 | 01370 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513033154.0 | ||
| 264 | 0 | _c19951221 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.92.10.3032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenedict, C R | |
| 245 | 0 | 0 |
_aNew variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. _h[electronic resource] |
| 260 |
_bCirculation _cNov 1995 |
||
| 300 |
_a3032-40 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarotid Artery Thrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKringles |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadverse effects |
| 700 | 1 | _aRefino, C J | |
| 700 | 1 | _aKeyt, B A | |
| 700 | 1 | _aPakala, R | |
| 700 | 1 | _aPaoni, N F | |
| 700 | 1 | _aThomas, G R | |
| 700 | 1 | _aBennett, W F | |
| 773 | 0 |
_tCirculation _gvol. 92 _gno. 10 _gp. 3032-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.92.10.3032 _zAvailable from publisher's website |
| 999 |
_c7585715 _d7585715 |
||